First Choice Healthcare Solutions, Inc. (FCHS)
OTCMKTS · Delayed Price · Currency is USD
0.0120
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT
FCHS Market Cap
FCHS has a market cap or net worth of $402.09 thousand as of September 18, 2025. Its market cap has decreased by -93.58% in one year.
Market Cap
402.09K
Enterprise Value
28.83M
Revenue
-4.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 7, 2011, FCHS's market cap has decreased from 110.00M to 402.09K, a decrease of -99.63%. That is a compound annual growth rate of -31.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 402.09K | 134.62% |
| Dec 31, 2024 | 171.38K | 79.62% |
| Dec 29, 2023 | 95.41K | -77.73% |
| Dec 30, 2022 | 428.46K | -72.77% |
| Dec 31, 2021 | 1.57M | -52.25% |
| Dec 29, 2020 | 3.30M | -42.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |